ABOUT US  

iPLATO’s mobile health solutions have proven to transform patient services and reduce health inequalities across populations. Responding to international demand for mHealth the company is currently expanding into the United States, India and Europe.

Serving millions of patients and thousands of healthcare professionals every day iPLATO  has emerged as the leader in mobile health. Across this network, participating healthcare organisations use iPLATO solutions to promote smoking cessation, weight loss, childhood immunisation, vascular checks and cancer screening as well as offer mobile services for people with diabetes, hypertension, epilepsy and HIV. [Read More]

 

FEATURED PRODUCTS  

IPLATO careSUPPORT

iPLATO careSUPPORT underpins our healthcare provider partners long term condition management and behavioural change programmes. It consists of a comprehensive range of modules to support patient self care.

A selection of iPLATO careSUPPORT modules:

  • Medication Support - to improve patient adherence to medication.
  • Carer Support - to make life easier for carers.
  • Education Support - to increase motivation for treatment.
  • Patient Diary - to enable self monitoring, reporting and sharing.
  • Text Consultation - to allow auditable doctor-patient interaction.

Long term condition management and behavioural change is an area of rapid growth for iPLATO and mHealth. Our target conditions are:

  • Epilepsy
  • HIV
  • Diabetes
  • Hypertension
  • Asthma
  • Depression
  • Smoking Cessation
  • Weight Loss
  • Physical Inactivity

We welcome innovative clinicians and academic institutions to get in touch to work with us to trial new concepts and develop new evidence.

BREAKING NEWS

iPLATO set to help General Practice reach Government Immunisation Targets

London, 20 August 2014 - iPLATO is the UK leader in mHealth and a preferred provider for surgery - patient communications across general practice. Over the next few weeks, on behalf of all GP’s across the UK, iPLATO will facilitate the delivery of alerts, advice and support about flu jabs to millions of patients.

 [Read More]




iPLATO Research concludes: patients are (mostly) good

London, 10 July 2014 - Recent research from Imperial College London suggests that almost six million patients a year are turning to A&E because they cannot get an appointment with their GP. At the same time, iPLATO Research published a report concluded that 180,000 people used the iPLATO system to cancel their appointment during the 2013/14 financial year.

 [Read More]




iPLATO helps GPs free up over 180,000 urgent appointments in one year

“A&E is creaking at the seams. It’s not broken, but it’s struggling” said Professor Sir Bruce Keogh, NHS Medical Director at the publication of the Urgent and Emergency Care Review in November 2013. Accidents & Emergency has become a hot political topic over the last years, often used as the ultimate measure for how the coalition runs the country’s health service.

 [Read More]







[Back to Top]